Search research articles
Contact Us
Filters
Showing results (701-710 of 830) with videos related to
Page
of 83
Sort By:
Cardiovascular Drugs and Therapy
|
May 3, 2014
Galectin-3: a modifiable risk factor in heart failure
Rudolf A de Boer, A Rogier van der Velde, Christian Mueller, et al.
Radiology
|
November 1, 1993
Prospective comparison of T2-weighted fast spin-echo, with and without fat suppression, and conventional spin-echo pulse sequences in the upper abdomen
L H Schwartz, S E Seltzer, C M Tempany, et al.
European Journal of Heart Failure
|
May 30, 2002
Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure
Monica R Shah, Vic Hasselblad, Sandra S Stinnett, et al.
The American Journal of Cardiology
|
January 19, 1995
Acute hemodynamic effects of the prostacyclin analog 15AU81 in severe congestive heart failure
J H Patterson, K F Adams, M Gheorghiade, et al.
The American Journal of Clinical Nutrition
|
September 13, 2005
Soy protein containing isoflavones does not decrease colorectal epithelial cell proliferation in a randomized controlled trial
Kenneth F Adams, Paul D Lampe, Katherine M Newton, et al.
Medicine
|
March 1, 1979
Response to saralasin and angiotensin's role in essential and renal hypertension
N K Hollenberg, G H Williams, D F Adams, et al.
Transplantation
|
June 15, 1997
Effects of pentoxifylline on renal function and blood pressure in cardiac transplant recipients: a randomized trial
R P Frantz, B S Edwards, L J Olson, et al.
The American Journal of Managed Care
|
October 9, 2014
Impact of hypertension on healthcare costs among children
Todd P Gilmer, Patrick J O'Connor, Alan R Sinaiko, et al.
Physical Chemistry Chemical Physics : PCCP
|
October 4, 2014
Understanding the adsorption mechanism of noble gases Kr and Xe in CPO-27-Ni, CPO-27-Mg, and ZIF-8
O V Magdysyuk, F Adams, H-P Liermann, et al.
Toxicologic Pathology
|
October 24, 2019
Carcinogenicity Assessment of Daprodustat (GSK1278863), a Hypoxia-Inducible Factor (HIF)-Prolyl Hydroxylase Inhibitor
David F Adams, Mark S Watkins, Luc Durette, et al.
Page
of 83
Search research articles
Search
Showing results (701-710 of 830) with videos related to
Sort By:
Page
of 83
Cardiovascular Drugs and Therapy
|
May 3, 2014
Galectin-3: a modifiable risk factor in heart failure
Rudolf A de Boer, A Rogier van der Velde, Christian Mueller, et al.
Radiology
|
November 1, 1993
Prospective comparison of T2-weighted fast spin-echo, with and without fat suppression, and conventional spin-echo pulse sequences in the upper abdomen
L H Schwartz, S E Seltzer, C M Tempany, et al.
European Journal of Heart Failure
|
May 30, 2002
Dissociation between hemodynamic changes and symptom improvement in patients with advanced congestive heart failure
Monica R Shah, Vic Hasselblad, Sandra S Stinnett, et al.
The American Journal of Cardiology
|
January 19, 1995
Acute hemodynamic effects of the prostacyclin analog 15AU81 in severe congestive heart failure
J H Patterson, K F Adams, M Gheorghiade, et al.
The American Journal of Clinical Nutrition
|
September 13, 2005
Soy protein containing isoflavones does not decrease colorectal epithelial cell proliferation in a randomized controlled trial
Kenneth F Adams, Paul D Lampe, Katherine M Newton, et al.
Medicine
|
March 1, 1979
Response to saralasin and angiotensin's role in essential and renal hypertension
N K Hollenberg, G H Williams, D F Adams, et al.
Transplantation
|
June 15, 1997
Effects of pentoxifylline on renal function and blood pressure in cardiac transplant recipients: a randomized trial
R P Frantz, B S Edwards, L J Olson, et al.
The American Journal of Managed Care
|
October 9, 2014
Impact of hypertension on healthcare costs among children
Todd P Gilmer, Patrick J O'Connor, Alan R Sinaiko, et al.
Physical Chemistry Chemical Physics : PCCP
|
October 4, 2014
Understanding the adsorption mechanism of noble gases Kr and Xe in CPO-27-Ni, CPO-27-Mg, and ZIF-8
O V Magdysyuk, F Adams, H-P Liermann, et al.
Toxicologic Pathology
|
October 24, 2019
Carcinogenicity Assessment of Daprodustat (GSK1278863), a Hypoxia-Inducible Factor (HIF)-Prolyl Hydroxylase Inhibitor
David F Adams, Mark S Watkins, Luc Durette, et al.
Page
of 83